Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Berman

Showing results (511-520 of 609) with videos related to

Pageof 61
Sort By:
Leukemia|February 8, 2008
A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal diseaseP G Maslak, T Dao, M Gomez, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 16, 2012
Altered neurochemical profile after traumatic brain injury: (1)H-MRS biomarkers of pathological mechanismsJanna L Harris, Hung-Wen Yeh, In-Young Choi, et al.
Seminars in Oncology|June 1, 1992
A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemiaJ E Kolitz, S J Kempin, A Schluger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1985
13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemiaZ A Arlin, R Mertelsmann, E Berman, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|March 20, 2015
Addressing Disparities in Stroke Prevention for Atrial Fibrillation: Educational OpportunitiesRachel Karcher, Adam E Berman, Hartmut Gross, et al.
Journal of Psychiatric Research|May 23, 2023
BDNF and stress/mood-related interactions on emotional disorder symptoms, executive functioning, and deliberate self-harmCasey R Guillot, Megan E Kelly, Noah B Phillips, et al.
Cancer Research|December 1, 1983
Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancerE Berman, R E Wittes, B Leyland-Jones, et al.
European Journal of Immunology|May 1, 1991
VH gene usage in humans: biased usage of the VH6 gene in immature B lymphoid cellsJ E Berman, K G Nickerson, R R Pollock, et al.
International Immunology|January 1, 1989
Immunoglobulin VH gene expression in human B cell lines and tumors: biased VH gene expression in chronic lymphocytic leukemiaT Logtenberg, M E Schutte, G Inghirami, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 19, 2010
EAAC1 gene deletion alters zinc homeostasis and exacerbates neuronal injury after transient cerebral ischemiaSeok Joon Won, Byung Hoon Yoo, Angela M Brennan, et al.
Pageof 61

Showing results (511-520 of 609) with videos related to

Sort By:
Pageof 61
Leukemia|February 8, 2008
A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal diseaseP G Maslak, T Dao, M Gomez, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 16, 2012
Altered neurochemical profile after traumatic brain injury: (1)H-MRS biomarkers of pathological mechanismsJanna L Harris, Hung-Wen Yeh, In-Young Choi, et al.
Seminars in Oncology|June 1, 1992
A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemiaJ E Kolitz, S J Kempin, A Schluger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1985
13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemiaZ A Arlin, R Mertelsmann, E Berman, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|March 20, 2015
Addressing Disparities in Stroke Prevention for Atrial Fibrillation: Educational OpportunitiesRachel Karcher, Adam E Berman, Hartmut Gross, et al.
Journal of Psychiatric Research|May 23, 2023
BDNF and stress/mood-related interactions on emotional disorder symptoms, executive functioning, and deliberate self-harmCasey R Guillot, Megan E Kelly, Noah B Phillips, et al.
Cancer Research|December 1, 1983
Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancerE Berman, R E Wittes, B Leyland-Jones, et al.
European Journal of Immunology|May 1, 1991
VH gene usage in humans: biased usage of the VH6 gene in immature B lymphoid cellsJ E Berman, K G Nickerson, R R Pollock, et al.
International Immunology|January 1, 1989
Immunoglobulin VH gene expression in human B cell lines and tumors: biased VH gene expression in chronic lymphocytic leukemiaT Logtenberg, M E Schutte, G Inghirami, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 19, 2010
EAAC1 gene deletion alters zinc homeostasis and exacerbates neuronal injury after transient cerebral ischemiaSeok Joon Won, Byung Hoon Yoo, Angela M Brennan, et al.
Pageof 61